148 related articles for article (PubMed ID: 16543963)
1. Marburg I polymorphism of factor VII-activating protease and risk of recurrent venous thromboembolism.
Gulesserian T; Hron G; Endler G; Eichinger S; Wagner O; Kyrle PA
Thromb Haemost; 2006 Jan; 95(1):65-7. PubMed ID: 16543963
[TBL] [Abstract][Full Text] [Related]
2. The G534E-polymorphism of the gene encoding the factor VII-activating protease is a risk factor for venous thrombosis and recurrent events.
Ahmad-Nejad P; Dempfle CE; Weiss C; Bugert P; Borggrefe M; Neumaier M
Thromb Res; 2012 Sep; 130(3):441-4. PubMed ID: 22421107
[TBL] [Abstract][Full Text] [Related]
3. Inflammatory bowel disease is a risk factor for recurrent venous thromboembolism.
Novacek G; Weltermann A; Sobala A; Tilg H; Petritsch W; Reinisch W; Mayer A; Haas T; Kaser A; Feichtenschlager T; Fuchssteiner H; Knoflach P; Vogelsang H; Miehsler W; Platzer R; Tillinger W; Jaritz B; Schmid A; Blaha B; Dejaco C; Eichinger S
Gastroenterology; 2010 Sep; 139(3):779-87, 787.e1. PubMed ID: 20546736
[TBL] [Abstract][Full Text] [Related]
4. Homozygosity in the single nucleotide polymorphism Ser128Arg in the E-selectin gene associated with recurrent venous thromboembolism.
Jilma B; Kovar FM; Hron G; Endler G; Marsik CL; Eichinger S; Kyrle PA
Arch Intern Med; 2006 Aug 14-28; 166(15):1655-9. PubMed ID: 16908800
[TBL] [Abstract][Full Text] [Related]
5. Marburg I polymorphism of factor VII-activating protease is associated with idiopathic venous thromboembolism.
Hoppe B; Tolou F; Radtke H; Kiesewetter H; Dörner T; Salama A
Blood; 2005 Feb; 105(4):1549-51. PubMed ID: 15486068
[TBL] [Abstract][Full Text] [Related]
6. Family history for venous thromboembolism and the risk for recurrence.
Hron G; Eichinger S; Weltermann A; Minar E; Bialonczyk C; Hirschl M; Stain M; Gartner V; Kyrle PA
Am J Med; 2006 Jan; 119(1):50-3. PubMed ID: 16431184
[TBL] [Abstract][Full Text] [Related]
7. Anticoagulation period in idiopathic venous thromboembolism. How long is enough?
Farraj RS
Saudi Med J; 2004 Jul; 25(7):848-51. PubMed ID: 15235686
[TBL] [Abstract][Full Text] [Related]
8. Circulating P-selectin and the risk of recurrent venous thromboembolism.
Kyrle PA; Hron G; Eichinger S; Wagner O
Thromb Haemost; 2007 Jun; 97(6):880-3. PubMed ID: 17549288
[TBL] [Abstract][Full Text] [Related]
9. 6 versus 30 months anticoagulation for recurrent venous thrombosis in patients with high factor VIII.
Eischer L; Gartner V; Schulman S; Kyrle PA; Eichinger S;
Ann Hematol; 2009 May; 88(5):485-90. PubMed ID: 18931845
[TBL] [Abstract][Full Text] [Related]
10. Tissue factor pathway inhibitor and the risk of recurrent venous thromboembolism.
Hoke M; Kyrle PA; Minar E; Bialonzcyk C; Hirschl M; Schneider B; Kollars M; Weltermann A; Eichinger S
Thromb Haemost; 2005 Oct; 94(4):787-90. PubMed ID: 16270631
[TBL] [Abstract][Full Text] [Related]
11. Venous thromboembolism: risk factors for recurrence.
Zhu T; Martinez I; Emmerich J
Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):298-310. PubMed ID: 19228602
[TBL] [Abstract][Full Text] [Related]
12. Abnormally short activated partial thromboplastin time values are associated with increased risk of recurrence of venous thromboembolism after oral anticoagulation withdrawal.
Legnani C; Mattarozzi S; Cini M; Cosmi B; Favaretto E; Palareti G
Br J Haematol; 2006 Jul; 134(2):227-32. PubMed ID: 16846482
[TBL] [Abstract][Full Text] [Related]
13. The risk of early recurrent venous thromboembolism after oral anticoagulant therapy in patients with the G20210A transition in the prothrombin gene.
Eichinger S; Minar E; Hirschl M; Bialonczyk C; Stain M; Mannhalter C; Stümpflen A; Schneider B; Lechner K; Kyrle PA
Thromb Haemost; 1999 Jan; 81(1):14-7. PubMed ID: 10348706
[TBL] [Abstract][Full Text] [Related]
14. Factor VII-activating protease in patients with acute deep venous thrombosis.
Sidelmann JJ; Vitzthum F; Funding E; Münster AM; Gram J; Jespersen J
Thromb Res; 2008; 122(6):848-53. PubMed ID: 18394684
[TBL] [Abstract][Full Text] [Related]
15. High frequency of factor V Leiden in surgical patients with symptomatic venous thromboembolism despite prophylaxis.
Baba-Ahmed M; Le Gal G; Couturaud F; Lacut K; Oger E; Leroyer C
Thromb Haemost; 2007 Feb; 97(2):171-5. PubMed ID: 17264942
[TBL] [Abstract][Full Text] [Related]
16. Overweight, obesity, and the risk of recurrent venous thromboembolism.
Eichinger S; Hron G; Bialonczyk C; Hirschl M; Minar E; Wagner O; Heinze G; Kyrle PA
Arch Intern Med; 2008 Aug; 168(15):1678-83. PubMed ID: 18695082
[TBL] [Abstract][Full Text] [Related]
17. Gene polymorphisms implicated in influencing susceptibility to venous and arterial thromboembolism: frequency distribution in a healthy German population.
Hoppe B; Tolou F; Dörner T; Kiesewetter H; Salama A
Thromb Haemost; 2006 Oct; 96(4):465-70. PubMed ID: 17003923
[TBL] [Abstract][Full Text] [Related]
18. Extended treatment for venous thromboembolism: how long is long enough?
Cosmi B; Palareti G
Curr Hematol Rep; 2004 Sep; 3(5):375-81. PubMed ID: 15341706
[TBL] [Abstract][Full Text] [Related]
19. Polymorphism in the beta2-adrenergic receptor and lipoprotein lipase genes as risk determinants for idiopathic venous thromboembolism: a multilocus, population-based, prospective genetic analysis.
Zee RY; Cook NR; Cheng S; Erlich HA; Lindpaintner K; Ridker PM
Circulation; 2006 May; 113(18):2193-200. PubMed ID: 16651467
[TBL] [Abstract][Full Text] [Related]
20. Marburg I polymorphism of factor VII-activating protease and risk of recurrent venous thromboembolism.
Hoppe B; Dörner T; Kiesewetter H; Salama A
Thromb Haemost; 2006 May; 95(5):907-8; author reply 908. PubMed ID: 16676090
[No Abstract] [Full Text] [Related]
[Next] [New Search]
